Identifier |
20180306_nanos_posters_170 |
Title |
Baseline OCT Findings in Phase 3 RESCUE and REVERSE Trials |
Creator |
Robert Sergott, Barrett Katz |
Subject |
Genetic Disease, Optic neuropathy, Diagnostic Tests (ERG, VER, OCT, HRT, mfERG, etc) Eyelid & adnexal disease |
Description |
rAAV2/2-ND4 is an investigational gene therapy facilitating allotopic transgene expression. We report baseline spectral domain OCT of the RNFL and GCL in two Phase 3 trials. |
Date |
2018-03 |
Language |
eng |
Format |
application/pdf |
Source |
2018 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS 2018: Poster Presentations |
Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
Rights Management |
Copyright 2018. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s61013gq |
Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
Contributor Primary |
Robert Sergott |
Contributor Secondary |
Barrett Katz |
Setname |
ehsl_novel_nam |
ID |
1309590 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s61013gq |